| Company name | Secuped |
| Year of establishment | 2025 |
| Sector | Life Sciences & Health |
| Website | https://secuped.com/cms/ |
| Status | Active |
Secuped
Secuped is a medtech company creating an at‑home device that automatically measures foot temperatures daily at risk points to detect early signs of ulcers in diabetic patients. Targeting the highest‑risk 6% of diabetics, its solution aims to prevent severe infections and amputations by enabling timely intervention.
This investment is managed by
Bart Hoenen, Investment Manger (LEH) at UNIIQ.



